Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
{(4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-[(4-amino-1H-indol-3-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
{(4Z)-2-[(1R,2R)-1-Amino–hydroxypropyl]-4–(amino–indol–methylene)–5–oxo–dihydroimidazol–acetic acid is a synthetic small molecule with the molecular formula C17H19N5O4 and a monoisotopic mass of approximately 357.14 g/mol[7][5]. It is listed in DrugBank as an experimental compound (DB01641), but there are no approved indications or clinical trials associated with it[8][5]. The structure features an imidazole ring substituted with both amino and indole groups. No mechanism of action or pharmacological activity has been reported in public databases. There are no known brand names or marketed products containing this compound.
- Other names
- (4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-(4-amino-1H-indol-3-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-1-acetic acid2-[((4Z)-4-(4-aminoindolylmethylene)-2-(aminohydroxypropyl)-5-dioxoimidazolyl]acetic acidDB01641DB-01641DB 01641
Beyond the preview
Go deeper on {(4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-[(4-amino-1H-indol-3-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on {(4Z)-2-[(1R,2R)-1-Amino-2-hydroxypropyl]-4-[(4-amino-1H-indol-3-yl)methylene]-5-oxo-4,5-dihydro-1H-imidazol-1-yl}acetic acid.